Lewis Katz School of Medicine

In the lab for a lifetime … and beyond
Type: News Story
In a class of 180 incoming students, it’s easy to be anonymous. But Dr. Carson Schneck, M.D., PhD., doesn’t let that happen to the doctors-in-training at Temple University’s School of Medicine. Before the students walk into his "Human Gross Anatomy" classroom, he knows each and every one of them.
August 25, 2008
Tumor-inhibiting protein discovered by Temple researchers could be effective in the treatment of leukemia
Type: News Story
Angiocidin, a tumor-inhibiting novel protein discovered by Temple University researchers, may also have a role as a new therapeutic application in treating leukemia, according to a study by the researchers.
July 15, 2008

Pages